Status:
COMPLETED
Evaluation of the Impact of SpO2 Averaging Time on Performance of an Automatic FiO2 Control System: a Randomized Study
Lead Sponsor:
Czech Technical University in Prague
Collaborating Sponsors:
Motol University Hospital
Conditions:
Neonatal Respiratory Distress
Very Low Birth Weight Infant
Eligibility:
All Genders
2+ years
Phase:
NA
Brief Summary
The aim of the study is to determine the preferred oximeter averaging setting during automated control of FiO2 (A-FiO2) in infants receiving respiratory support and supplemental oxygen.
Detailed Description
There are 7 different averaging time settings available with PRICO (Acutronic Medical Systems AG, Hirzel, Switzerland), but after over a year of experience there is no clear clinical impression of the...
Eligibility Criteria
Inclusion
- All VLBW on respiratory support and oxygen requirements after 2 weeks of age in the NICU are eligible after parental informed consent is obtained.
Exclusion
- Parental informed consent is not obtained
- Recording device for automated control of FiO2 is not available
Key Trial Info
Start Date :
February 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05274386
Start Date
February 17 2022
End Date
December 30 2022
Last Update
March 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Motol University Hospital
Prague, Czechia, 15500